Tokyo
Japan
17
2026-05-21
The entities that hold a legal rights for patent applications filed by inventor OGITANI Yusuke:
Yusuke OGITANI from Tokyo, JP has applied for patents for these inventions. The list has both pending applications and granted patents:
COMBINATION OF ANTIBODY-DRUG CONJUGATE AND TUBULIN INHIBITOR
#2 | 2025-02-13ANTIBODY-DRUG CONJUGATE
#3 | 2024-03-14Antibody-drug conjugate
#4 | 2024-01-25METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE
#5 | 2022-01-27COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH PARP INHIBITOR
#6 | 2021-09-23COMBINATION OF ANTIBODY-DRUG CONJUGATE AND TUBULIN INHIBITOR
#7 | 2020-12-10Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate
#8 | 2020-09-10Antibody-drug conjugate
#9 | 2019-10-31THERAPY FOR DRUG-RESISTANT CANCER BY ADMINISTRATION OF ANTI-HER2 ANTIBODY/DRUG CONJUGATE
#10 | 2019-03-14Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate
#11 | 2019-01-10Antibody-drug conjugate
#12 | 2018-03-15Antibody-drug conjugate produced by binding through linker having hydrophilic structure
#13 | 2017-02-09(Anti-HER2 antibody)-drug conjugate
#14 | 2016-11-17Anti-HER2 antibody-drug conjugate
#15 | 2016-09-29Antibody-drug conjugate
#16 | 2015-12-10Antibody-drug conjugate produced by binding through linker having hydrophilic structure
#17 | 2015-10-22Antibody-drug conjugate
1327486 ⎘